Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib

Dogan E., Saygili U., Posaci C., Tuna B., Caliskan S., ALTUNYURT S., ...Daha Fazla

FERTILITY AND STERILITY, cilt.82, ss.1115-1120, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 82
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.fertnstert.2004.06.033
  • Dergi Adı: FERTILITY AND STERILITY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1115-1120
  • Anahtar Kelimeler: endometriosis, cyclooxygenase type 2 inhibitors, rofecoxib, vascular endothelial growth factor, ENDOTHELIAL GROWTH-FACTOR, PERITONEAL-FLUID, MOLECULAR-BASIS, MESSENGER-RNA, FACTOR VEGF, EXPRESSION, ANGIOGENESIS, WOMEN, COX-2, MODEL
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: To investigate the effects of cyclooxygenase-2 (COX-2) inhibitor rofecoxib on endometrial explants and on peritoneal vascular endothelial growth factor (VEGF) levels in the rat endometriosis model.